We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $817M
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
+16.1%
1 Year Est. Return
+22.58%
3 Year Est. Return
+98.16%
5 Year Est. Return
+143.24%
10 Year Est. Return
+598.39%
AUM
$817M
AUM Growth
+$90.8M
Cap. Flow
+$1.66M
Cap. Flow %
0.2%
Top 10 Hldgs %
63.21%
Holding
81
New
6
Increased
35
Reduced
32
Closed
1

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$6.1M
2
BROS icon
Dutch Bros
BROS
+$3.53M
3
LLY icon
Eli Lilly
LLY
+$3.21M
4
ISRG icon
Intuitive Surgical
ISRG
+$2.81M
5
SYK icon
Stryker
SYK
+$2.21M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$6.38M
2
PAYC icon
Paycom
PAYC
+$5.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$4.55M
4
CRM icon
Salesforce
CRM
+$3.75M
5
NVDA icon
NVIDIA
NVDA
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 39.98%
2 Healthcare 13.64%
3 Consumer Discretionary 12.64%
4 Communication Services 12.29%
5 Financials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
76
Caterpillar
CAT
$362B
$262K 0.03%
+246
New +$216K
AMD icon
77
Advanced Micro Devices
AMD
$855B
$253K 0.03%
+435
New +$178K
IBRX icon
78
ImmunityBio
IBRX
$8.58B
$214K 0.03%
23,800
GE icon
79
GE Aerospace
GE
$325B
$211K 0.03%
+564
New +$177K
PLTR icon
80
Palantir
PLTR
$411B
$200K 0.02%
+1,710
New +$233K
ADBE icon
81
Adobe
ADBE
$100B
-923
Closed -$224K

Similar funds

Dillon & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Dillon & Associates held 81 positions worth $817M, up 13% from $726M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Dillon & Associates's Q2 2026 filing shows 6 new, 35 increased, 32 reduced and 1 closed positions. Its largest new stake was Dutch Bros: 61,521 shares worth $4.43M. The largest sale was Novo Nordisk, an estimated $6.38M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q2 2026 buy was Dutch Bros: 61,521 shares worth $4.43M.
  • Dillon & Associates added most to American Express in Q2 2026, an estimated $6.1M increase.
  • Dillon & Associates's biggest Q2 2026 reduction was Novo Nordisk, cutting an estimated $6.38M.
  • Dillon & Associates fully exited Adobe in Q2 2026, selling an estimated $224K.
  • Dillon & Associates's ten largest holdings make up 63% of its $817M portfolio in Q2 2026.
  • Dillon & Associates opened 6 new positions and closed 1 in Q2 2026.
  • Dillon & Associates's portfolio value rose 13% quarter-over-quarter to $817M.

Based on Dillon & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.